- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/404 - Indoles, e.g. pindolol
Patent holdings for IPC class A61K 31/404
Total number of patents in this class: 5100
10-year publication summary
|
353
|
352
|
372
|
392
|
384
|
361
|
371
|
376
|
362
|
85
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1581 |
93 |
| Novartis AG | 11238 |
83 |
| Boehringer Ingelheim International GmbH | 4629 |
57 |
| The Regents of the University of California | 18943 |
46 |
| The Johns Hopkins University | 5377 |
43 |
| F. Hoffmann-La Roche AG | 7958 |
39 |
| Allergan, Inc. | 2600 |
37 |
| Bristol-myers Squibb Company | 5080 |
33 |
| Pfizer Inc. | 3322 |
33 |
| Janssen Pharmaceuticals, Inc. | 399 |
32 |
| Centre National de La Recherche Scientifique | 9632 |
28 |
| Arena Pharmaceuticals, Inc. | 381 |
28 |
| Astellas Pharma Inc. | 1145 |
28 |
| Achillion Pharmaceuticals, Inc. | 176 |
27 |
| Janssen Pharmaceutica N.V. | 3839 |
25 |
| Generics [UK] Limited | 132 |
25 |
| Katholieke Universiteit Leuven | 1035 |
25 |
| Takeda Pharmaceutical Company Limited | 2961 |
24 |
| Merck Sharp & Dohme LLC | 3689 |
23 |
| Wyeth | 632 |
21 |
| Other owners | 4350 |